MITOMYCINE ACCORD 20 mg, powder for solution for injection / infusion or route intravesical bottle
Active ingredients: MITOMYCINE
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for solution for infusionbottleintraveineuse;intravésicale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- MITOMYCINE ACCORD 20 mg, poudre pour solution injectable / perfusion ou voie intravésicale
- Pharmaceutical form
- poudre pour solution injectable pour perfusion ou
- Route of administration
- intraveineuse;intravésicale
- Presentation description
- 1 flacon(s) en verre de 20 mg
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 May 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65355771CIP75504036CIP133400955040361Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MITOMYCINEpoudre | 20 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.